Precision Medicine

The Ivy’s bioethics center will collaborate with colleagues at University of Copenhagen to develop frameworks around “black box” medicine.

They are building a research registry of data from 30,000 patients. The goal: help scientists advance sleep medicine.

There simply aren't enough genetic counselors to deliver testing results to every patient.

Technology allows people to screen for hereditary cancers. But what happens afterward?

The pharma company and the precision medicine start-up are chasing better cancer care.

The initiative is similar to the All of Us program being run by the National Institutes of Health in the United States

A new study tackles 3 vexing questions: Do humans have genes that enable regeneration, could they be used to fight cancer, and can AI find them?

Caltech researchers continue to refine the microscopic device, whose potential continues to grow.

The majority of the new funding comes from Chinese genomics giant iCarbonX.

Pharma giant Bristol-Myers Squibb is the newest investor in the genomic testing company.

Why the cutting-edge analytics firm is joining forces with Baptist Health South Florida's year-old cancer center.

"The next wave of biomedical insights is coming from cross-institutional collaborations that produce rapidly increasing amounts of multi-omics data."

Companies face challenges, from courting customers to charming regulators.

The experts have weighed in. These are the healthtech companies that won 2017.

Why Frost & Sullivan expects the genome-editing technology to be a financial boon.

State-level privacy policies have a substantial impact on incidence of genetic testing, according to a new study.

Costco co-founder Jeffrey Brotman died in August, but friend says the new institute will be a lasting treatment to his generosity.

DNA tests may be selling well in advance of the holidays. This week Senator Chuck Schumer cautioned about how they may use consumer genetic info.

As therapies like Kymriah and Yescarta transform medicine, how can hospitals take advantage of analytics to improve processes and patient outcomes?

The ambitious precision medicine initiative looks to sequence 1 million Americans to inform public health.

In addition to the approval, the agency announced that it is streamlining the review process for NGS tumor tests.

“I know of no other health system with such dedication to putting patients and their health first," the new Initiative's director said.

“We need to use data better,” the billionaire wrote in a blog post announcing a huge investment.

For centuries, population-based evidence has laid the foundation of healthcare. Precision medicine will change that.

The testing company also stated that it raised $65 million in an ongoing funding round.